198 related articles for article (PubMed ID: 22314912)
21. The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.
Han C; Huang X; Hua R; Song S; Lyu L; Ta N; Zhu J; Zhang P
Medicine (Baltimore); 2017 Aug; 96(32):e7467. PubMed ID: 28796034
[TBL] [Abstract][Full Text] [Related]
22. Association of human
Yuan M; Yu C; Yu K
Cancer Cell Int; 2020; 20():164. PubMed ID: 32435155
[TBL] [Abstract][Full Text] [Related]
23. Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
Chang K; Deng S; Lu W; Wang F; Jia S; Li F; Yu L; Chen M
PLoS One; 2012; 7(7):e41519. PubMed ID: 22911807
[TBL] [Abstract][Full Text] [Related]
24. DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.
Ma WJ; Lv GD; Zheng ST; Huang CG; Liu Q; Wang X; Lin RY; Sheyhidin I; Lu XM
World J Gastroenterol; 2010 Feb; 16(5):641-7. PubMed ID: 20128036
[TBL] [Abstract][Full Text] [Related]
25. Association of XPA polymorphism with breast cancer risk: A meta-analysis.
Zhang Y; Guo Q; Yin X; Zhu X; Zhao L; Zhang Z; Wei R; Wang B; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11276. PubMed ID: 29953005
[TBL] [Abstract][Full Text] [Related]
26. Association Between the Interleukin-10-1082G/A, -592C/A, -819C/T Gene Polymorphism and HIV-1 Susceptibility: A Meta-Analysis.
Jiang C; Liu S; Liu S; Li Z; Chen P; Chen L
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):61-67. PubMed ID: 27785918
[TBL] [Abstract][Full Text] [Related]
27. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.
Dong Z; Guo W; Zhou R; Wan L; Li Y; Wang N; Kuang G; Wang S
J Clin Gastroenterol; 2008 Sep; 42(8):910-5. PubMed ID: 18645534
[TBL] [Abstract][Full Text] [Related]
29. Association between ATM polymorphisms and cancer risk: a meta-analysis.
Shen L; Yin ZH; Wan Y; Zhang Y; Li K; Zhou BS
Mol Biol Rep; 2012 May; 39(5):5719-25. PubMed ID: 22203481
[TBL] [Abstract][Full Text] [Related]
30. Relationship between
Imani MM; Basamtabar M; Akbari S; Sadeghi E; Sadeghi M
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541204
[No Abstract] [Full Text] [Related]
31. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China.
Guo W; Zhou RM; Wan LL; Wang N; Li Y; Zhang XJ; Dong XJ
J Cancer Res Clin Oncol; 2008 Feb; 134(2):263-70. PubMed ID: 17653764
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
[TBL] [Abstract][Full Text] [Related]
34. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
35. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
36. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
37. CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies.
Zheng Y; Xu Y; Zhou BY; Sun L; Yu PB; Zhang L; Xu J; Wang JJ
Ann Clin Lab Sci; 2018 Jul; 48(4):538-545. PubMed ID: 30143500
[TBL] [Abstract][Full Text] [Related]
38. The effect of MUC1 rs4072037 functional polymorphism on cancer susceptibility: evidence from published studies.
Duan F; Song C; Dai L; Cui S; Zhang X; Zhao X
PLoS One; 2014; 9(4):e95651. PubMed ID: 24755768
[TBL] [Abstract][Full Text] [Related]
39. Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
Wu H; Qiao N; Wang Y; Jiang M; Wang S; Wang C; Hu L
PLoS One; 2013; 8(11):e76372. PubMed ID: 24260099
[TBL] [Abstract][Full Text] [Related]
40. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
